Literature DB >> 30444537

The effect of repeated stimulated granulocyte donations on hematopoietic indexes in donors: a 24-year donor center experience.

James Szymanski1, James Troendle2, Susan Leitman1, Hong Hong1, Yu Ying Yau1, Cathy Cantilena1.   

Abstract

BACKGROUND: Short- and long-term effects of mobilization regimens in hematopoietic stem cell and granulocyte donors have been well characterized. In this study, we examined the longitudinal hematopoietic changes related to repeat stimulated granulocyte donation. STUDY DESIGN AND METHODS: Complete blood counts for consecutive granulocyte donors between October 1994 and May 2017 were compared to unstimulated granulocyte donors. Plateletpheresis donors served as controls. The longitudinal change in precollection white blood cell (WBC) counts for these donor groups were modeled using a linear mixed-effects model. The investigated variables were granulocyte, lymphocyte, and monocyte counts and the granulocyte collection yield. Contrasts were performed to explore the effect of donation number on precollection counts.
RESULTS: For the granulocyte-colony-stimulating factor plus dexamethasone (G-CSF/Dex)-stimulated group, both the granulocyte and the lymphocyte counts decreased 6.51 × 109 /L (-23.1%, p < 0.001) and 0.21 × 109 /L (-20.4%, p < 0.001), respectively, between Donation 1 and Donation 20. This effect was still present at the 3- to 4-year interval (b = -0.0008313, SE = 0.00029, p = 0.004). For the unstimulated donor group between Donation 1 and Donation 20, the lymphocyte count decreased by 0.62 × 109 /L (-51.5%, p < 0.001). This effect was only significant up to Year 2 (b = -0.0026, SE = 0.0010, p = 0.013).
CONCLUSIONS: Past granulocyte donations were found to have a statistically strong negative effect on precollection granulocyte counts and lymphocyte counts and decreased granulocyte yield both in the G-CSF/Dex-stimulated donors and the unstimulated donors. In this statistical model, for both these groups, the effect of past donations on granulocyte and WBC counts were still detectable 2 years later.
© 2018 AABB.

Entities:  

Mesh:

Year:  2018        PMID: 30444537      PMCID: PMC7365331          DOI: 10.1111/trf.15000

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  20 in total

1.  Short- and long-term haematological surveillance of healthy donors of allogeneic peripheral haematopoietic progenitors mobilized with G-CSF: a single institution prospective study.

Authors:  C Tassi; P L Tazzari; F Bonifazi; V Giudice; A Nannetti; F Ricci; S Rizzi; G Bandini; R Conte
Journal:  Bone Marrow Transplant       Date:  2005-08       Impact factor: 5.483

2.  Efficacy and side effects of granulocyte collection in healthy donors.

Authors:  Franziska Brockmann; Michael Kramer; Martin Bornhäuser; Gerhard Ehninger; Kristina Hölig
Journal:  Transfus Med Hemother       Date:  2013-07-19       Impact factor: 3.747

3.  Immune function in blood donors following short-term lymphocytapheresis.

Authors:  V S Blanchette; J Dunne; D Steele; S McPhail; S Sklar; D Algom; M A Richter; G Rock
Journal:  Vox Sang       Date:  1985       Impact factor: 2.144

4.  Safety and efficacy of hematopoietic stem cell collection from mobilized peripheral blood in unrelated volunteers: 12 years of single-center experience in 3928 donors.

Authors:  Kristina Hölig; Michael Kramer; Frank Kroschinsky; Martin Bornhäuser; Thilo Mengling; Alexander H Schmidt; Claudia Rutt; Gerhard Ehninger
Journal:  Blood       Date:  2009-08-07       Impact factor: 22.113

5.  Follow-up of healthy donors receiving granulocyte colony-stimulating factor for peripheral blood progenitor cell mobilization and collection. Results of the Spanish Donor Registry.

Authors:  Javier de la Rubia; Felipe de Arriba; Cristina Arbona; María J Pascual; Concha Zamora; Andrés Insunza; Dorleta Martínez; Carmen Paniagua; Miguel A Díaz; Miguel A Sanz
Journal:  Haematologica       Date:  2008-04-02       Impact factor: 9.941

6.  Efficacy of transfusion with granulocytes from G-CSF/dexamethasone-treated donors in neutropenic patients with infection.

Authors:  Thomas H Price; Michael Boeckh; Ryan W Harrison; Jeffrey McCullough; Paul M Ness; Ronald G Strauss; W Garrett Nichols; Taye H Hamza; Melissa M Cushing; Karen E King; Jo-Anne H Young; Eliot Williams; Janice McFarland; Jennifer Holter Chakrabarty; Steven R Sloan; David Friedman; Samir Parekh; Bruce S Sachais; Joseph E Kiss; Susan F Assmann
Journal:  Blood       Date:  2015-09-02       Impact factor: 22.113

7.  Granulocyte transfusions from G-CSF-stimulated donors for the treatment of severe infections in neutropenic pediatric patients with onco-hematological diseases.

Authors:  Simone Cesaro; Pierangelo Chinello; Giustina De Silvestro; Piero Marson; Giorgio Picco; Stefania Varotto; Silvia Pittalis; Luigi Zanesco
Journal:  Support Care Cancer       Date:  2002-11-12       Impact factor: 3.603

8.  Lower risk for serious adverse events and no increased risk for cancer after PBSC vs BM donation.

Authors:  Michael A Pulsipher; Pintip Chitphakdithai; Brent R Logan; Willis H Navarro; John E Levine; John P Miller; Bronwen E Shaw; Paul V O'Donnell; Navneet S Majhail; Dennis L Confer
Journal:  Blood       Date:  2014-04-15       Impact factor: 22.113

Review 9.  Mobilization and collection of peripheral blood stem cells in healthy donors: risks, adverse events and follow-up.

Authors:  V Moalic
Journal:  Pathol Biol (Paris)       Date:  2012-11-27

10.  Adverse events among 2408 unrelated donors of peripheral blood stem cells: results of a prospective trial from the National Marrow Donor Program.

Authors:  Michael A Pulsipher; Pintip Chitphakdithai; John P Miller; Brent R Logan; Roberta J King; J Douglas Rizzo; Susan F Leitman; Paolo Anderlini; Michael D Haagenson; Seira Kurian; John P Klein; Mary M Horowitz; Dennis L Confer
Journal:  Blood       Date:  2009-02-03       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.